JG
FRTX

Jefferies Group’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Jefferies Group’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2
Closed -$4K – 3206
2015
Q2 		$4K Buy
+2
New +$6.27K ﹤0.01% 3046
2014
Q3 		– Sell
-6
Closed -$23K – 2523
2014
Q2 		$23K Buy
+6
New +$22.6K ﹤0.01% 1971

Other funds holding FRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Jefferies Group's FRTX Position: Q3 2015 in Review

Jefferies Group sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2015, closing a stake of 2 shares — an estimated $4K sold.

Jefferies Group first reported a position in FRTX in Q2 2014 and held it in 2 quarters. The position peaked at $23K in Q2 2014. 49 funds tracked by Wall St. Rank hold FRTX as of Q3 2015.

  • Jefferies Group reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Jefferies Group sold 2 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $4K.
  • Jefferies Group first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2014 and held it in 2 quarters.
  • Jefferies Group's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $23K in Q2 2014.
  • 49 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2015.

Based on Jefferies Group's 13F filing for Q3 2015, filed 13 Nov 2015.